Rhumbline Advisers Artivion, Inc. Call Options Transaction History
Rhumbline Advisers
- $109 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AORT
# of Institutions
174Shares Held
35.8MCall Options Held
33KPut Options Held
900-
Black Rock Inc. New York, NY6.64MShares$195 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$82.2 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$82 Million1.94% of portfolio
-
Macquarie Group LTD Australia, C32.75MShares$80.6 Million0.08% of portfolio
-
Morgan Stanley New York, NY2.45MShares$71.9 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.18B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...